|
|
|
Volumn 12, Issue 63, 2003, Pages 5-8
|
|
New indication in complications of high myopia: No sustained benefit
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIGLAUCOMA AGENT;
BENZOPORPHYRIN DERIVATIVE;
PLACEBO;
PHOTOSENSITIZING AGENT;
PORPHYRIN;
ARTICLE;
BLEEDING;
CATARACT;
CATARACT EXTRACTION;
CENTRAL SCOTOMA;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG INDICATION;
DRUG MARKETING;
EDEMA;
EXTRAVASATION;
FOLLOW UP;
GLAUCOMA;
HIGH MYOPIA;
HUMAN;
INFLAMMATION;
LOW BACK PAIN;
LOW LEVEL LASER THERAPY;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NONHUMAN;
PHOTODYNAMIC THERAPY;
PHOTOSENSITIVITY;
RANDOMIZED CONTROLLED TRIAL;
RAT;
RETINA DETACHMENT;
RETINA SURGERY;
SUBRETINAL NEOVASCULARIZATION;
TERATOGENICITY;
THORAX PAIN;
TRABECULECTOMY;
TREATMENT OUTCOME;
VISUAL ACUITY;
VISUAL DISORDER;
COMPARATIVE STUDY;
DRUG SCREENING;
MYOPIA;
PHOTOTHERAPY;
CHOROIDAL NEOVASCULARIZATION;
DRUG EVALUATION;
HUMANS;
MYOPIA;
PHOTOSENSITIZING AGENTS;
PHOTOTHERAPY;
PORPHYRINS;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 0038616100
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (4)
|
